Kiniksa Pharmaceuticals International (KNSA) Retained Earnings (2017 - 2026)
Kiniksa Pharmaceuticals International (KNSA) reported Retained Earnings of -$414.11 million for Q2 2026, compared with -$494.77 million a year earlier.
Powered by 
Analysis
Kiniksa Pharmaceuticals International (KNSA) Retained Earnings (2017 - 2026) Analysis & Trends
At the end of FY2025, Kiniksa Pharmaceuticals International posted Retained Earnings of -$462.14 million.
- By year, Retained Earnings came in at -$521.14 million in FY2024, -$477.95 million in FY2023, -$492.03 million in FY2022 and -$675.4 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Retained Earnings since Q1 2020.
- Per Business Quant data, the three quarters before Q2 2026 came in at -$439.55 million (Q1 2026), -$462.14 million (Q4 2025) and -$476.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 171.67 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -17.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 63.27 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 40.86 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 12.59 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -22.28 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.20 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 112.09 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 15.69 Bn |
| 10 | Kiniksa Pharmaceuticals International | 11.64 Bn | 10.38 Bn | 220.03 Mn | -414.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -414.11 Mn |
| Mar 31, 2026 | -439.55 Mn |
| Dec 31, 2025 | -462.14 Mn |
| Sep 30, 2025 | -476.34 Mn |
| Jun 30, 2025 | -494.77 Mn |
| Mar 31, 2025 | -512.60 Mn |
| Dec 31, 2024 | -521.14 Mn |
| Sep 30, 2024 | -512.26 Mn |
| Jun 30, 2024 | -499.56 Mn |
| Mar 31, 2024 | -495.65 Mn |
| Dec 31, 2023 | -477.95 Mn |
| Sep 30, 2023 | -503.19 Mn |
| Jun 30, 2023 | -489.33 Mn |
| Mar 31, 2023 | -504.30 Mn |
| Dec 31, 2022 | -492.03 Mn |
| Sep 30, 2022 | -496.50 Mn |
| Jun 30, 2022 | -720.59 Mn |
| Mar 31, 2022 | -700.61 Mn |
| Dec 31, 2021 | -675.40 Mn |
| Sep 30, 2021 | -639.06 Mn |
API Access
Kiniksa Pharmaceuticals International Retained Earnings API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=retained-earnings&ticker=KNSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "retained-earnings", "ticker": "KNSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=retained-earnings&ticker=KNSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();